LL-37 5 MG. 1 UNITS LL-37 BIOACTIVES PEPTIDES (excluded of 20 USD Postage fee/order)

LL-37

LL-37 is a naturally occurring antimicrobial peptide (AMP) and the only member of the cathelicidin family of peptides found in humans. This peptide plays an essential role in the innate immune system, acting as the first line of defense against infections. LL-37 exhibits a wide range of biological activities, including antimicrobial, immunomodulatory, and wound-healing properties. Its unique mechanism of action has made it a subject of growing interest in medical research and potential therapeutic applications.

What is LL-37?

LL-37 is a cationic, amphipathic peptide derived from the precursor protein cathelicidin antimicrobial peptide (CAMP). It is produced by various cell types, including epithelial cells, neutrophils, and macrophages. LL-37 has broad-spectrum activity against bacteria, viruses, and fungi. Beyond its antimicrobial properties, LL-37 modulates inflammation, promotes tissue repair, and plays a role in the regulation of the immune response.

Dosage Forms and Strengths

LL-37 is primarily available for research and clinical studies in synthetic peptide form. While not yet widely commercialized for therapeutic purposes, LL-37 is typically synthesized as a lyophilized powder and reconstituted for use in laboratory or experimental settings. Doses used in studies vary depending on the purpose, with typical concentrations ranging from micrograms to milligrams per application.

Brand and Generic Names

LL-37 is generally referred to by its peptide sequence name rather than a brand name. However, companies specializing in peptide synthesis may offer it under proprietary identifiers. As research progresses, specific formulations may be developed for clinical use, potentially accompanied by branded names.

Indications for Use

LL-37 has shown promise in various medical conditions due to its diverse functions. Key potential indications include:

1. Wound Healing: LL-37 accelerates tissue repair and re-epithelialization in chronic wounds such as diabetic ulcers.
2. Infectious Diseases: It has activity against drug-resistant bacterial strains, including MRSA.
3. Inflammatory Diseases: LL-37 modulates excessive immune responses, making it a candidate for diseases like psoriasis and inflammatory bowel disease (IBD).
4. Cancer Therapy: LL-37 has been studied for its dual role in promoting or inhibiting tumor growth, depending on the context.

Mechanism of Action

LL-37 exerts its antimicrobial activity by interacting with microbial membranes. Its cationic nature enables it to bind to negatively charged bacterial membranes, disrupting their integrity and causing cell death. Additionally, LL-37 regulates the immune system by:

• Recruiting immune cells to infection sites.
• Modulating cytokine production to reduce inflammation.
• Promoting angiogenesis and tissue repair.

The peptide also enhances the effectiveness of other antimicrobial agents and prevents biofilm formation by pathogens.

Administration and Dosage

Currently, LL-37 is administered in experimental settings via injection, topical application, or inhalation, depending on the condition being studied. For wound healing, LL-37 is typically applied topically, while systemic infections may require intravenous administration. Dosage recommendations are not standardized and depend on the disease model and research objectives. Ongoing clinical trials aim to establish safe and effective dosing guidelines.

Side Effects and Precautions

Although LL-37 has shown promise, it is not without potential side effects. Studies have reported the following:

• Local Irritation: When applied topically, LL-37 can cause mild irritation or erythema.
• Pro-Inflammatory Effects: In some cases, LL-37 may exacerbate inflammation, particularly in autoimmune diseases.
• Cytotoxicity: High concentrations of LL-37 may damage host tissues.

Precautions include careful dose optimization and consideration of the patient’s condition. Further research is required to understand its long-term safety and potential interactions with other treatments.

Conclusion

LL-37 is a multifunctional peptide with remarkable potential in various medical applications, ranging from antimicrobial therapy to wound healing and immunomodulation. Its unique mechanism of action and versatility make it a promising candidate for addressing pressing medical challenges, such as antibiotic resistance and chronic inflammatory diseases. However, the lack of standardized dosage guidelines and the need for further safety evaluations highlight the necessity of ongoing research. As scientific understanding of LL-37 expands, it may pave the way for innovative therapeutic approaches in the future.

• Model: LL-37
• Brand: